share_log

Piper Sandler Downgrades Aptinyx to Neutral, Lowers Price Target to $2

Benzinga Real-time News ·  Aug 12, 2022 14:34

Piper Sandler analyst Christopher Raymond downgrades Aptinyx (NASDAQ:APTX) from Overweight to Neutral and lowers the price target from $6 to $2.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment